Skip to content
Screener

Nature's Sunshine Products NATR Immunity — Net Sales

Other product segments

General health
$48.9M+3.2%
Digestive
$28.71M+2.9%
Cardiovascular
$19.83M+1.9%
Personal care
$6.76M+27.4%
Weight management
$4.06M-12.0%

Similar metrics at other companies

General Mills logo
GISPet — Net Sales
$746.6M+5.8%
Wabash National logo
WNCNew trailers — Net Sales
$317.05M+1.6%
Amazon logo
AMZNNet product sales — Net Sales
$71.3B+11.5%
Amazon logo
AMZNNet service sales — Net Sales
$110.22B+20.2%
Lowe's Companies logo
LOWOther Sales — Net Sales
$551M+30.0%
Lowe's Companies logo
LOWPaint Sales — Net Sales
$1.25B+0.4%

Other financials

Income statement

See full
Revenue$117.0M+1.9%
Gross profit$86.2M+4.7%
Operating income$5.5M+28.2%
Net income$3.5M-33.7%
EPS (diluted)$0.19-32.1%

Balance sheet

See full
Cash & equivalents$82.5M+1.4%
Total debt$21.4M+37.1%
Total equity$169.3M+3.4%
Total assets$259.8M+1.9%

Cash flow

See full
Operating cash flow-$1.8M-171%
CapEx$2.8M+106%
Free cash flow-$1.9M-165%

Valuation

See full
Market cap$288.04M-2.3%
Enterprise value$226.97M-0.8%
P/E15.9×-4.5×
P/S0.6×-0.1×

Profitability

See full
Gross margin73.2%+1.4pp
Operating margin6%+1.6pp
Net margin3.7%+0.5pp
FCF margin3.7%-1.2pp

Returns & leverage

See full
Return on equity10.9%+1.9pp
Debt / equity0.1×0.0×
Current ratio2.6×+0.3×

Where this comes from

Reported directly by Nature's Sunshine Products in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Nature's Sunshine Products’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054468
Three Months Ended June 30, 2026AsiaEuropeNorth AmericaLatin America and OtherTotal
General health$21,486$9,589$16,242$1,582$48,899
Immune3,0791,8833,3214478,730
Cardiovascular12,8252,8953,71339819,831
Digestive9,6016,50710,0812,51928,708
Personal care3,5301,1241,8792236,756
Weight management2,4766967151744,061
Total net sales by segment$52,997$22,694$35,951$5,343$116,985

Item 1. Financial Statements (Unaudited)

FAQ

What is Nature's Sunshine Products's immunity — net sales?
Nature's Sunshine Products (NATR) reported immunity — net sales of $8.73M in Q2 2026.
How has Nature's Sunshine Products's immunity — net sales changed year-over-year?
Nature's Sunshine Products's immunity — net sales decreased by 13.4% year-over-year, from $10.09M to $8.73M.
What is the long-term trend for Nature's Sunshine Products's immunity — net sales?
Over 4 years (2021 to 2025), Nature's Sunshine Products's immunity — net sales has grown at a 5.6% compound annual growth rate (CAGR), from $32.79M to $40.82M.
What does immunity — net sales mean?
This metric represents the total revenue generated from the sale of nutritional and wellness products specifically formulated to support immune system health. It serves as a key indicator of consumer demand for the company's immunity-focused product portfolio and reflects the segment's contribution to overall corporate top-line performance. Tracking this figure helps investors assess the growth trajectory and market penetration of the company's health-oriented product categories.

Ask your AI about Nature's Sunshine Products's immunity — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude